Vipshop Not Done De...
Health Care: Drugs
MannKind Corporation (MNKD: NASDAQ)
$5.36 0.05 | 0.94%
05/21/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -169.37M | -160.80M | -170.56M | -220.10M |
| Operating Gains/Losses | 799.00K | -4.00K | 644.00K | 12.87M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -290.00K | 830.00K | 1.12M | 582.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 44.00K | 2.67M | -4.29M | -6.37M |
| (Decrease) Increase In Other Current Liabilities | 15.08M | 6.04M | -7.55M | -12.27M |
| (Increase) Decrease In Other Working Capital | 0.00 | 87.00K | 267.00K | -36.00K |
| Other Non-Cash Items | 21.02M | 11.20M | 13.57M | 20.21M |
| Net Cash From Continuing Operations | -119.86M | -123.84M | -148.65M | -184.08M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -119.86M | -123.84M | -148.65M | -184.08M |
| Sale of Property, Plant & Equipment | 77.00K | 93.00K | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 3.83M | 2.00M | 17.80M |
| Purchases of Property, Plant & Equipment | -637.00K | -6.86M | -9.54M | -18.85M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -4.18M | -2.00M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -560.00K | -2.94M | -11.72M | -3.05M |
| Issuance of Debt | 12.75M | 53.00M | 182.78M | 135.00M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 0.00 | 10.94M | 17.02M | 61.51M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 166.83M | -547.00K | -3.39M | -7.00M |
| Net Cash From Financing Activities | 179.58M | 63.39M | 196.42M | 189.51M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 59.16M | -63.38M | 36.04M | 2.37M |
Portfolios with MNKD
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- Userbiomed
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserHoldings
- Contributor10 Most Shorted Stocks in B...
- ContributorBreakout Stocks Of The Week...
Latest MNKD Headlines from TheStreet
- MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It 04.17.13 | 09:04 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- 3 Highly Shorted Stocks Under $5 Bought Up By Hedge Funds 04.09.13 | 01:04 pm
- Biotech Stock Mailbag: MannKind, Ariad, Oncolytics Biotech 04.05.13 | 07:04 am
- 8 Stocks Under $5 Seeing Institutional And Insider Buying 04.02.13 | 03:04 pm
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
- 10 Stocks Insiders And Hedge Funds Think Will Go Higher 03.11.13 | 01:03 pm
- These 3 Insider Favorites Are Trading Significantly Below Target Price 01.14.13 | 12:01 pm
- Biotech 2013 Kickoff Party: J.P. Morgan Investor Confab 01.04.13 | 08:01 am
- 5 Stocks Insiders are Buying This Week 12.26.12 | 12:12 pm
Press Releases for MNKD
- MannKind Corporation To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.26.13 | 05:02 pm
- MannKind Corporation Reports 2012 Fourth Quarter And Full Year Financial Results - Business Wire 02.11.13 | 04:02 pm
- MannKind Corporation To Hold 2012 Fourth Quarter And Full Year Financial Results Conference Call On February 11, 2013 - Business Wire 02.04.13 | 05:02 pm
- MannKind Corporation To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.03.13 | 05:01 pm
- MannKind Corporation To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 05:11 pm
- Faruqi & Faruqi, LLP Launches An Investigation Against Mannkind Corp. (MNKD) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors - Business Wire 11.19.12 | 07:11 pm
- Colby And MannKind Sign License And Joint Development Agreement To Develop And Commercialize Cancer Immunotherapy Products - Business Wire 11.13.12 | 08:11 am
- MannKind Corporation Reports 2012 Third Quarter Financial Results - Business Wire 11.01.12 | 04:11 pm
- MannKind Corporation Reschedules 2012 Third Quarter Financial Results Conference Call To November 1, 2012 Due To Hurricane Sandy - Business Wire 10.29.12 | 02:10 pm
- MannKind Corporation To Hold 2012 Third Quarter Financial Results Conference Call On October 29, 2012 - Business Wire 10.22.12 | 06:10 pm
Partner Headlines for MNKD
- Mid-Afternoon Market Update: Markets Remain Down, Bankrate Rallies - Benzinga 04.12.13 | 03:04 pm
- Long MannKind's Afrezza: Shares Versus A Bull Call Spread - Seeking Alpha 12.01.12 | 07:12 am
- MannKind to Raise Funds - Analyst Blog - Zacks 10.18.12 | 07:10 pm
- MannKind Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga 10.18.12 | 09:10 am
- MNKD Enrolls Patients for Afrezza - Analyst Blog - Zacks 10.08.12 | 06:10 pm
- Company News for September 05, 2012 - Corporate Summary - NASDAQ 09.05.12 | 02:09 pm
- Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD - GuruFocus 07.09.12 | 01:07 pm
- Weekly Top Insider Buys: HRB, LPI, GCO, GAM, SONC, MNKD - GuruFocus 07.09.12 | 01:07 pm
- A123 Systems POPS to Lead 7 NASDAQ Top Percentage Winners - Wall St. Cheat Sheet 06.21.12 | 11:06 am
- MNKD Cancer Treatment Data Released - Analyst Blog - Zacks 06.01.12 | 06:06 pm
